Regeneron Announces Upcoming 2013 Investor Conference Presentations

     Regeneron Announces Upcoming 2013 Investor Conference Presentations

PR Newswire

TARRYTOWN, N.Y., April 18, 2013

TARRYTOWN, N.Y., April 18, 2013 /PRNewswire/ --Regeneron Pharmaceuticals,
Inc. (NASDAQ: REGN) will webcast management presentations at the following
investor conferences:

  oBaird's 2013 Growth Stock Conference on Wednesday, May 8, 2013. The
    presentation is scheduled for 10:45 a.m. Eastern Time (9:45 a.m. Central
    Time).

  oCredit Suisse 2013 Antibody Day on Friday, May 10, 2013. The presentation
    is scheduled for 7:45 a.m. Eastern Time.

  oBank of America Merrill Lynch 2013 Healthcare Conference on Tuesday, May
    14, 2013. The presentation is scheduled for 6:40 p.m. Eastern Time (3:40
    p.m. Pacific Time).

The presentations may be accessed through the Company's web site,
www.regeneron.com, on the 'Events and Presentations' page. An archived
version of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in
Tarrytown, New York that discovers, invents, develops, manufactures, and
commercializes medicines for the treatment of serious medical conditions.
Regeneron markets medicines for eye diseases, colorectal cancer, and a rare
inflammatory condition and has product candidates in development in other
areas of high unmet medical need, including hypercholesterolemia, oncology,
rheumatoid arthritis, asthma and atopic dermatitis. For additional
information about the company, please visit www.regeneron.com.

Contact Information:
Manisha Narasimhan, Ph.D.         Peter Dworkin
Investor Relations                 Corporate
                                   Communications
914.847.5126                       914.847.7640 
manisha.narasimhan@regeneron.com peter.dworkin@regeneron.com

SOURCE Regeneron Pharmaceuticals, Inc.

Website: http://www.regeneron.com